References
- Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395:44–52.
- Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm. 2006;318:103–117.
- Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16:731–741.
- Wang QS, Wang GF, Zhou J, et al. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. International Journal of Pharmaceutics.2016; 515:176–185.
- Xing L, Dawei C, Liping X, et al. Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. J Control Release. 2003;93:293–300.
- Zhang F. Melt-Extruded Eudragit® FS-based granules for colonic drug delivery. AAPS PharmSciTech. 2016;17:56–67.
- Huyghebaert N, Vermeire A, Remon JP. Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules. Eur J Pharm Sci. 2004;21:617–623.
- Gao C, Huang J, Jiao Y, et al. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets. Int J Pharm. 2006;322:104–112.
- He W, Du Q, Cao DY, et al. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm. 2008;348:35–45.
- Naeem M, Choi M, Cao J, et al. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy. Drug Design Dev Ther. 2015;9:3789–3799.
- Chan WA, Boswell CD, Zhang Z. Comparison of the release profiles of a water soluble drug carried by Eudragit-coated capsules in different in-vitro dissolution liquids. Powder Technol. 2001;119:26–32.
- Liu F, Merchant HA, Kulkarni RP, et al. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. Eur J Pharm Biopharm. 2011;78:151–157.
- Ibekwe VC, Fadda HM, Parsons GE, et al. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int J Pharm. 2006;308:52–60.
- McConnell EL, Short MD, Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J Control Release. 2008;130:154–160.
- Sharma P, Chawla A, Pawar P. Design, development, and optimization of polymeric based-colonic drug delivery system of Naproxen. Sci World J. 2013;2013:12.
- Akhgari A, Afrasiabi Garekani H, Sadeghi F, et al. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm. 2005;305:22–30.
- Liu H, Yang XG, Nie SF, et al. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation. Int J Pharm. 2007;332:115–124.
- Patel MM, Shah TJ, Amin AF, et al. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system. Pharm Dev Technol. 2009;14:62–69.
- Aguirre TA, Aversa V, Rosa M, et al. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: comparison between intestinal instillation and oral gavage. J Control Release. 2016;238:242–252.
- Luo JY, Zhong Y, Cao JC, et al. Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis. Biomed Pharmacother. 2011;65:111–117.